Kidney Disease Clinical Trials in Los Angeles

Showing 61-80 of 308 trials

Immunological Tolerance in Patients With Mismatched Kidney Transplants

NCT05806749

This study seeks to determine if administration of the drug belumosudil (KD025) will be safe and improve transplant tolerance in subjects undergoing combined Human Leukocyte Antigen (HLA) single haplotype-matched related or 0-3 antigen (at A, B, C, DR) HLA mismatched unrelated living donor kidney and hematopoietic stem cell transplantation.

End Stage Kidney DiseaseImmunological ToleranceKidney Transplant Failure and Rejection+1 more

University of California, Los Angeles16 participantsStarted Jul 2023

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

NCT03183245

The main purpose of this study is to compare the Human Acellular Vessel (HAV) with arteriovenous fistula (AVF) when used for hemodialysis access

Renal FailureEnd Stage Renal DiseaseHemodialysis+1 more

Humacyte, Inc.242 participantsStarted Sep 2017

Phoenix, Arizona, United States • Tucson, Arizona, United States • Irvine, California, United States +28 more locations

Immunological Tolerance in Patients With Mismatched Kidney Transplants

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

Kidney Disease Trials in Other Cities

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)

Prevention of Serious Adverse Events Following Angiography

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

Other Conditions in Los Angeles